Ocean Bio Chem (OBCI) 10-Q 15 May 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2014	15-May-14
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'OCEAN BIO CHEM INC	'
Entity Central Index Key	'0000350737	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Document Type	'10-Q	'
Document Period End Date	31-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	8,800,314

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current Assets:	'	'
Cash	$2,830,230	$3,071,887
Trade accounts receivable less allowances of approximately $45,000 and $93,000, respectively	2,968,136	4,413,656
Receivables due from affiliated companies	1,029,021	536,402
Inventories, net	8,763,691	7,367,894
Prepaid expenses and other current assets	773,663	621,107
Deferred tax asset	45,714	64,665
Total Current Assets	16,410,455	16,075,611
Property, plant and equipment, net	5,116,274	5,116,441
Other Assets:	'	'
Trademarks, trade names, royalty rights, and patents, net	902,921	920,269
Other assets	129,562	130,803
Total Other Assets	1,032,483	1,051,072
Total Assets	22,559,212	22,243,124
Current Liabilities:	'	'
Accounts payable - trade	1,491,157	1,013,829
Dividends payable	440,016	'
Current portion of long term debt	416,240	414,525
Income taxes payable	115,294	119,943
Accrued expenses payable	759,217	1,067,355
Total Current Liabilities	3,221,924	2,615,652
Deferred tax liability	216,553	237,635
Long term debt, less current portion	1,012,419	1,117,761
Total Liabilities	4,450,896	3,971,048
Shareholders' Equity:	'	'
Common stock - $.01 par value, 12,000,000 shares authorized; 8,864,888 and 8,749,888 shares issued	88,649	87,499
Additional paid in capital	8,855,060	8,805,460
Less cost of common stock in treasury, 64,574 and 79,941 shares, respectively	-52,529	-65,029
Accumulated other comprehensive loss	-270,617	-266,456
Retained earnings	9,265,710	9,482,128
Total Shareholders' Equity of Ocean Bio-Chem, Inc.	17,886,273	18,043,602
Noncontrolling interest	222,043	228,474
Total Shareholders' Equity	18,108,316	18,272,076
Total Liabilities and Shareholders' Equity	$22,559,212	$22,243,124

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]	'	'
Trade accounts receivable, allowance for doubtful accounts	$45,000	$93,000
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	12,000,000	12,000,000
Common stock, shares issued	8,864,888	8,749,888
Number of treasury shares delievered in connection with stock awards and stock option exercises	64,574	79,941

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Statements of Operation [Abstract]	'	'
Gross sales	$6,240,025	$6,651,028
Less: discounts, returns, and allowances	319,326	338,725
Net sales	5,920,699	6,312,303
Cost of goods sold	3,833,036	4,071,044
Gross profit	2,087,663	2,241,259
Operating Expenses:	'	'
Advertising and promotion	583,869	566,811
Selling and administrative	1,152,025	1,149,522
Total operating expenses	1,735,894	1,716,333
Operating income	351,769	524,926
Other income (expense)	'	'
Interest, net (expense)	-11,382	-17,401
Income before income taxes	340,387	507,525
Provision for income taxes	123,220	179,156
Net income	217,167	328,369
Loss attributable to noncontrolling interests	6,431	20,683
Net income attributable to Ocean Bio-Chem, Inc.	$223,598	$349,052
Earnings per common share - basic and diluted	$0.03	$0.04
Dividends per common share	$0.05	'

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Statements of Comprehensive Income [Abstract]	'	'
Net Income	$217,167	$328,369
Other comprehensive (loss) income:	'	'
Foreign currency translation adjustment	-4,161	-2,150
Comprehensive income	213,006	326,219
Comprehensive loss attributable to noncontrolling interests	6,431	20,683
Comprehensive income attributable to Ocean Bio-Chem, Inc.	$219,437	$346,902

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:	'	'
Net income	$217,167	$328,369
Adjustments to reconcile net income to net cash used in operating activities	'	'
Depreciation and amortization	201,005	186,497
Deferred income taxes	-2,131	14,269
Stock based compensation	'	4,586
Other operating non-cash items	-36,886	11,510
Changes in assets and liabilities:	'	'
Trade accounts receivable	1,493,516	-272,555
Inventories	-1,395,797	-843,617
Other assets	1,241	1,242
Prepaid expenses and other current assets	-152,556	-151,049
Receivables due from affiliated companies	-492,619	-62,224
Accounts payable and other accrued expenses	164,541	31,204
Net cash used in operating activities	-2,519	-751,768
Cash flows from investing activities:	'	'
Purchases of property, plant and equipment	-183,490	-119,440
Net cash used in investing activities	-183,490	-119,440
Cash flows from financing activities:	'	'
Payments on long-term debt	-103,627	-100,758
Proceeds from exercise of stock options	63,250	'
Net cash used in financing activities	-40,377	-100,758
Effect of exchange rates on cash	-15,271	-2,001
Net decrease in cash	-241,657	-973,967
Cash at beginning of period	3,071,887	1,508,385
Cash at end of period	2,830,230	534,418
Supplemental disclosure of cash flow information:	'	'
Cash paid for interest during period	13,974	17,674
Cash paid for income taxes during period	$130,000	$77,100

Summary_of_Accounting_Policies

Summary of Accounting Policies	3 Months Ended
	Mar. 31, 2014
Summary of Accounting Policies [Abstract]	'
SUMMARY OF ACCOUNTING POLICIES	'
	1	SUMMARY OF ACCOUNTING POLICIES
	Interim reporting
	The accompanying unaudited condensed consolidated financial statements include the accounts of Ocean Bio-Chem, Inc. and its subsidiaries, all of which are wholly-owned, and OdorStar Technology, LLC (“OdorStar”), a joint venture in which the Company has a controlling interest.  All significant intercompany transactions and balances have been eliminated in consolidation.  Certain prior-period data have been reclassified to conform to the current period presentation.  Unless the context indicates otherwise, the term “Company” refers to Ocean Bio-Chem, Inc. and its subsidiaries.
	The unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.
	The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods.  The results of operations for the three months ended March 31, 2014 are not necessarily indicative of the results to be expected for the year ending December 31, 2014.
	The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.
	Use of estimates
	The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates and assumptions.

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2014
Recent Accounting Pronouncements [Abstract]	'
RECENT ACCOUNTING PRONOUNCEMENTS	'
	2	RECENT ACCOUNTING PRONOUNCEMENTS
	There have been no accounting pronouncements or changes in accounting pronouncements during the three months ended March 31, 2014 that are expected to have a material impact on the Company’s financial position, results of operations or cash flows.  Accounting pronouncements that became effective during the three months ended March 31, 2014 did not have a material impact on disclosures or on the Company’s financial position, results of operations or cash flows.

Inventories

Inventories	3 Months Ended
	Mar. 31, 2014
Inventories [Abstract]	'
INVENTORIES	'
	3	INVENTORIES
	The composition of inventories at March 31, 2014 and December 31, 2013 are as follows:
			March 31,			December 31,
			2014			2013
	Raw materials		$	3,642,178		$	3,262,769
	Finished goods			5,423,809			4,407,421
	Inventories, gross			9,065,987			7,670,190
	Inventory reserves			-302,296	)		(302,296	)
	Inventories, net		$	8,763,691		$	7,367,894
	The inventory reserves shown in the table above reflect slow moving and obsolete inventory.
	The Company manages an inventory program for one of its customers to improve the promotion of the Company's products.  The Company manages the inventory levels at the customer’s warehouses and recognizes revenue as the products are sold by the customer.  The inventories managed at the customer’s warehouses amounted to approximately $413,000 and $408,000 at March 31, 2014 and December 31, 2013, respectively, and are included in inventories, net on the balance sheet.

Property_Plant_Equipment

Property, Plant, & Equipment	3 Months Ended
	Mar. 31, 2014
Property, Plant, & Equipment [Abstract]	'
PROPERTY, PLANT, & EQUIPMENT	'
	4	PROPERTY, PLANT, & EQUIPMENT
	The Company’s property, plant and equipment consisted of the following at March 31, 2014 and December 31, 2013:
		Estimate	March 31,			December 31,
		Useful Life	2014			2013
	Land		$	278,325		$	278,325
	Building and improvements	30 years		4,632,565			4,632,565
	Manufacturing and warehouse equipment	6-20 years		8,160,173			8,160,173
	Office equipment and furniture	3-5 years		834,505			830,950
	Construction in process			160,103			19,604
	Leasehold improvements	10-15 years		419,315			419,315
	Automobile	3 years		32,263			32,263
	Property, plant and equipment, gross			14,517,249			14,373,195
	Less accumulated depreciation			(9,400,975	)		(9,256,754	)
	Property, plant and equipment, net		$	5,116,274		$	5,116,441

Odorstar_Joint_Venture

Odorstar Joint Venture	3 Months Ended
	Mar. 31, 2014
Odorstar Joint Venture [Abstract]	'
ODORSTAR JOINT VENTURE	'
	5	ODORSTAR JOINT VENTURE
	In 2010, the Company and BBL Distributors, LLC (“BBL”) organized OdorStar. OdorStar owns patents that relate to a formula and delivery system (the “Patents”), for use with products containing chlorine dioxide, designed to safely prevent and eliminate odors relating to mold, mildew and other sources of unpleasant odors. Under OdorStar’s Operating Agreement, each of the Company and BBL are required to make monthly payments to OdorStar, based on their purchases of products incorporating the patented technology, to provide for operating expenses. In addition, prior to August 6, 2013, OdorStar paid a royalty, funded by the Company and BBL based upon their respective sales of products encompassing the patented technology, to an unaffiliated company that sold the Patents to BBL (BBL subsequently contributed the Patents to OdorStar). On August 6, 2013, the Company purchased the unaffiliated company’s royalty rights for $160,000. The Company and BBL Distributors, LLC share equally in profits or losses from OdorStar. Because the Company manages OdorStar, it has consolidated OdorStar in its financial statements. The Company’s consolidated balance sheets include approximately $507,000 and $474,000 in assets and $0 and $16,000 in liabilities of OdorStar at March 31, 2014 and December 31, 2013, respectively. The Company’s consolidated statements of operations include OdorStar’s operating losses of approximately $13,000 and $41,000 during the three months ended March 31, 2014 and 2013, respectively. During 2013, the Company paid BBL's funding obligation with respect to a portion of OdorStar's operating expenses, and BBL issued a note to the Company in the amount of $111,420, which was outstanding on March 31, 2014 and December 31, 2013. Payments of interest only on the note are required until December 2015, at which time all principal on the note is due and payable. In the event principal is not paid when due, the Company has the right to demand an adjustment in the Company's and BBL's capital interests in OdorStar, with the unpaid amounts treated as an additional capital contribution by the Company.

Revolving_Line_of_Credit

Revolving Line of Credit	3 Months Ended
	Mar. 31, 2014
Revolving Line of Credit and Long Term Debt [Abstract]	'
REVOLVING LINE OF CREDIT	'
	6	REVOLVING LINE OF CREDIT
	On July 6, 2011, the Company, together with its subsidiary, Kinpak Inc. (“Kinpak”), entered into a Credit Agreement with Regions Bank (and, pursuant to an Equipment Finance Addendum to the Credit Agreement, Regions Equipment Finance Corporation (“REFCO”)).  Under the Credit Agreement, the Company’s revolving line of credit with Regions Bank was renewed.  The terms of the revolving line of credit, as renewed, provide that the Company may borrow up to the lesser of (i) $6 million or (ii) a borrowing base equal to 80% of eligible accounts receivable plus 50% of eligible inventory.  Interest on the revolving line of credit is payable at the 30 day LIBOR rate plus 1.74% per annum (unless the Company’s debt service coverage ratio (net profit plus taxes, interest, depreciation, amortization and rent expense divided by debt service plus interest and lease/rent expense) falls to or below 2.0 to 1, in which case the interest is payable at the 30 day LIBOR rate plus 2.75% per annum).  In no event will the interest rate be less than 2.0% per annum.  Outstanding amounts under the revolving line of credit are payable on demand.  If no demand is made, the Company may repay and reborrow funds from time to time.  The Company’s obligations under the revolving line of credit are secured by the Company’s accounts receivable and inventory, as well as real property and equipment at Kinpak’s Montgomery, Alabama facility.   The Company’s obligations under the revolving line of credit and the term loan discussed in Note 7 below are cross-collateralized.  Interest on amounts borrowed under the revolving line of credit is payable in monthly installments on outstanding average balances, with all outstanding principal and interest payable on July 6, 2014.  The Credit Agreement includes financial covenants requiring a minimum debt service coverage ratio of 1.75 to 1.00, tested on a rolling four-quarter basis, and a maximum debt to capitalization ratio (funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly.  At March 31, 2014, the Company was in compliance with these covenants. At March 31, 2014 and December 31, 2013, the Company had no borrowings under the revolving line of credit.

Long_Term_Debt

Long Term Debt	3 Months Ended
	Mar. 31, 2014
Revolving Line of Credit and Long Term Debt [Abstract]	'
LONG TERM DEBT	'
	7	LONG TERM DEBT
	On July 6, 2011, under the Equipment Finance Addendum to the Credit Agreement, REFCO provided to the Company a $2,430,000 term loan with a fixed interest rate of 3.54%.  Principal and interest on the term loan are payable in equal monthly installments through July 6, 2017, the date on which the term loan matures.  The proceeds of the term loan were used to pay the Company’s remaining obligations under a lease agreement relating to industrial revenue bonds used to fund the expansion of Kinpak’s facilities and acquisition of related equipment.  At March 31, 2014, approximately $1,413,000 was outstanding under the term loan.
	At March 31, 2014 and December 31, 2013, the Company was obligated under various capital lease agreements covering equipment utilized in the Company’s operations.  The capital leases, aggregating $15,341 and $19,532 at March 31, 2014 and December 31, 2013, respectively, have varying maturities through 2015 and carry interest rates ranging from 7% to 14%.
	The following table provides information regarding the Company’s long term debt at March 31, 2014 and December 31, 2013:
			Current Portion				Long Term Portion
			March 31,		December 31,		March 31,		December 31,
			2014		2013		2014		2013
	Term loan		$	406,652	$	403,074	$	1,006,666	$	1,109,680
	Capitalized equipment leases			9,588		11,451		5,753		8,081
	Total long term debt		$	416,240	$	414,525	$	1,012,419	$	1,117,761
	Required principal payments under the Company’s long term obligations are set forth below:
	12 month period ending March 31,
	2015		$	416,240
	2016			427,036
	2017			436,441
	2018			148,942
	Total		$	1,428,659

Related_Party_Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2014
Related Party Transactions [Abstract]	'
RELATED PARTY TRANSACTIONS	'
	8	RELATED PARTY TRANSACTIONS
	During the three months ended March 31, 2014 and 2013, the Company sold products to companies affiliated with its Chairman, President and Chief Executive Officer. The affiliated companies distribute the products outside of the United States and Canada. The Company also provides administrative services to these companies. Sales to the affiliated companies aggregated approximately $713,000 and $471,000 during the three months ended March 31, 2014 and 2013, respectively.  Administrative fees aggregated approximately $92,000 and $102,000 during the three months ended March 31, 2014 and 2013, respectively. The Company had accounts receivable from the affiliated companies in connection with the product sales and administrative services aggregating approximately $1,029,000 and $536,000 at March 31, 2014 and December 31, 2013, respectively. Transactions with the affiliated companies were made in the ordinary course of business.   While the terms of sale to the affiliated companies differed from the terms applicable to other customers, the affiliated companies bear their own warehousing, distribution, advertising, selling and marketing costs, as well as their own freight charges (the Company pays freight charges in connection with sales to its domestic customers on all but small orders).  Moreover, the Company does not pay sales commissions with respect to products sold to the affiliated companies.  As a result, the Company believes its profit margins with respect to sales to the affiliated companies are similar to the profit margins with respect to sales to its larger domestic customers.  Management believes that the sales transactions did not involve more than normal credit risk or present other unfavorable features.
	A subsidiary of the Company currently uses the services of an entity that is owned by its Chairman, President and Chief Executive Officer to conduct product research and development, marketing and advertising.  Under this arrangement, the Company paid the entity approximately $10,500 for each of the three month periods ended March 31, 2014 and 2013, under this arrangement.
	The Company leases office and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer.  The Company believes that the rental payments are below market rates.  See Note 9 for a description of the lease terms.
	A director of the Company is Regional Executive Vice President of an entity from which the Company sources most of its insurance needs at an arm’s length competitive basis.  During the three months ended March 31, 2014 and 2013, the Company paid an aggregate of approximately $217,000 and $183,000, respectively, in insurance premiums on policies obtained through the entity.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2014
Commitments and Contingencies [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	9	COMMITMENTS AND CONTINGENCIES
	The Company leases its executive offices and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer. On May 16, 2013, the term of the lease, which was scheduled to expire on May 1, 2018, was extended through December 31, 2023. The lease requires annual minimum base rent of $94,800 and provides for a maximum annual 2% increase in subsequent years, although the entity has not raised the minimum rent since the Company entered into a previous lease agreement in 1998. Additionally, the leasing entity is entitled to reimbursement of all taxes, assessments, and any other expenses that arise from ownership. Each of the parties to the lease has agreed to review the terms of the lease every three years at the request of the other party.  Rent expense under the lease was approximately $24,000 and $25,000 for the three months ended March 31, 2014 and 2013, respectively.
	The Company leases from the Alabama State Port Authority a 1.5 acre docking facility on the Alabama River, located approximately eleven miles from the Company’s Alabama manufacturing facility.  The lease expires on September 30, 2014, and requires the Company to pay rent and additional expenses totaling approximately $8,000 annually.
	On November 26, 2013, OdorStar and Kinpak filed a Second Amended Complaint in the United States District Court for the Southern District of Florida, amending a complaint initially filed on January 13, 2013. The Second Amended Complaint was filed against SMM Distributors LLC (now defunct) d/b/a Biocide Systems, and SMM Manufacturing, Inc. (collectively, "Biocide"). The Second Amended Complaint alleged that Biocide manufactured, used, sold and continues to sell an odor eliminating product that infringes OdorStar's U.S. patent relating to OdorStar's delivery system for use with products containing chlorine dioxide. Biocide denied the allegations of the Second Amended Complaint, and both the plaintiffs and defendants filed motions for summary judgment. On January 27, 2014, the District Court granted the defendants' motion for summary judgment and denied the plaintiffs' motion.
	OdorStar and Kinpak have appealed the judgment to the United States Court of Appeals for the Eleventh Circuit. The appeal is pending.
	On March 27, 2014, the defendants filed a motion with the District Court seeking payment by OdorStar and Kinpak of their attorneys’ fees and non-taxable costs in the amount of $259,550, based on, among other things, the defendants’ contention that the plaintiffs' patent infringement claims were vexatious and intended to intimidate the defendants into withdrawing from competition with the plaintiffs.  OdorStar and Kinpak filed an opposition to the motion, essentially denying the defendants' contentions and stating that defendants were not entitled to payment of their attorneys’ fees under applicable legal standards. The District Court has not yet ruled on the motion.

Dividends

Dividends	3 Months Ended
	Mar. 31, 2014
Dividends [Abstract]	'
DIVIDENDS	'
	10	DIVIDENDS
	On March 18, 2014, the Board of Directors of Ocean Bio-Chem, Inc.  declared a special cash dividend of $0.05 per common share payable on April 15, 2014 to all shareholders of record on April 1, 2014.  On April 1, 2014 there were 8,800,314 shares of common stock outstanding; as a result the Company recorded a $440,016 liability for dividends payable, which is reflected on the March 31, 2014 balance sheet.  In accordance with the action of the Board of Directors, the dividend was paid on April 15, 2014.

Earnings_Per_Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
EARNINGS PER SHARE	'
	11	EARNINGS PER SHARE
	Basic earnings per share is calculated based on net income attributable to Ocean Bio-Chem, Inc. and the weighted average number of shares outstanding during the reported period.  Diluted earnings per share reflect additional dilution from potential common stock issuable upon the exercise of outstanding stock options.  The following table sets forth the computation of basic and diluted earnings per common share, as well as a reconciliation of the weighted average number of common shares outstanding to the weighted average number of shares outstanding on a diluted basis.
			Three Months Ended
			March 31,
			2014		2013
	Earnings per common share -Basic
	Net income attributable to OBCI		$	223,598	$	349,052
	Weighted average number of common shares outstanding			8,690,074		8,398,385
	Earnings per common share - Basic		$	0.03	$	0.04
	Earnings per common share – Diluted
	Net income attributable to OBCI		$	223,598	$	349,052
	Weighted average number of common shares outstanding			8,690,074		8,398,385
	Dilutive effect of employee stock options			173,050		283,723
	Weighted average number of common shares outstanding - assuming dilution			8,863,124		8,682,108
	Earnings per common share - Diluted		$	0.03	$	0.04
	The Company had no stock options outstanding for each of the three month periods ended March 31, 2014 and 2013, respectively, that were anti-dilutive and therefore not included in the diluted earnings per common share calculation.

Securities_Authorized_for_Issu

Securities Authorized for Issuance under Equity Compensation Plans	3 Months Ended
	Mar. 31, 2014
Securities Authorized for Issuance under Equity Compensation Plans [Abstract]	'
SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS	'
	12.	SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS
	During the three months ended March 31, 2014, stock options to purchase an aggregate of 145,000 shares were exercised.  Following the withholding of an aggregate of 14,633 shares in connection with the net exercise feature of the stock options, the Company delivered an aggregate of 130,367 shares to the option holders who exercised their options.
	Stock compensation expense attributable to stock options was $0 and approximately $5,000 for the three months ended March 31, 2014 and 2013, respectively. There were no stock awards issued during the three months ended March 31, 2014 and 2013.
	At March 31, 2014, there was no unrecognized compensation expense related to stock options .
	The following table provides information at March 31, 2014 regarding outstanding stock options under the Company’s stock option plans. As used in the table below, “2002 NQ” refers to the Company’s 2002 Non-Qualified Stock Option Plan and “2008 NQ” refers to the Company’s 2008 Non-Qualified Stock Option Plan.
	Plan		Date	Options Outstanding		Exercisable	Exercise		Expiration	Weighted
			Granted			Options	Price		Date	Average
										Remaining Life
	2002NQ		4/3/06		40,000	40,000	$	1.08	4/2/16	2
	2002NQ		12/17/07		40,000	40,000	$	1.32	12/16/17	3.8
	2008NQ		1/11/09		40,000	40,000	$	0.69	1/10/19	4.9
	2008NQ		4/26/10		20,000	20,000	$	2.07	4/25/20	6.2
					140,000	140,000	$	1.18		3.9

Summary_of_Accounting_Policies1

Summary of Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2014
Summary of Accounting Policies [Abstract]	'
Interim reporting	'
	Interim reporting
	The accompanying unaudited condensed consolidated financial statements include the accounts of Ocean Bio-Chem, Inc. and its subsidiaries, all of which are wholly-owned, and OdorStar Technology, LLC (“OdorStar”), a joint venture in which the Company has a controlling interest.  All significant intercompany transactions and balances have been eliminated in consolidation.  Certain prior-period data have been reclassified to conform to the current period presentation.  Unless the context indicates otherwise, the term “Company” refers to Ocean Bio-Chem, Inc. and its subsidiaries.
	The unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.
	The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods.  The results of operations for the three months ended March 31, 2014 are not necessarily indicative of the results to be expected for the year ending December 31, 2014.
	The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.
Use of estimates	'
	Use of estimates
	The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates and assumptions.

Inventories_Tables

Inventories (Tables)	3 Months Ended
	Mar. 31, 2014
Inventories [Abstract]	'
Summary of composition of inventories	'
		March 31,				December 31,
		2014				2013
	Raw materials		$	3,642,178			$	3,262,769
	Finished goods			5,423,809				4,407,421
	Inventories, gross			9,065,987				7,670,190
	Inventory reserves			-302,296	)			(302,296	)
	Inventories, net		$	8,763,691			$	7,367,894

Property_Plant_Equipment_Table

Property, Plant, & Equipment (Tables)	3 Months Ended
	Mar. 31, 2014
Property, Plant, & Equipment [Abstract]	'
Summary of property, plant and equipment	'
			March 31,				December 31,
	Estimate		2014				2013
	Useful Life
	Land			$	278,325			$	278,325
	Building and improvements	30 years			4,632,565				4,632,565
	Manufacturing and warehouse equipment	6-20 years			8,160,173				8,160,173
	Office equipment and furniture	3-5 years			834,505				830,950
	Construction in process				160,103				19,604
	Leasehold improvements	10-15 years			419,315				419,315
	Automobile	3 years			32,263				32,263
	Property, plant and equipment, gross				14,517,249				14,373,195
	Less accumulated depreciation				(9,400,975	)			(9,256,754	)
	Property, plant and equipment, net			$	5,116,274			$	5,116,441

Long_Term_Debt_Tables

Long Term Debt (Tables)	3 Months Ended
	Mar. 31, 2014
Revolving Line of Credit and Long Term Debt [Abstract]	'
Summary of company's long term debt	'
		Current Portion				Long Term Portion
		March 31,		December 31,		March 31,		December 31,
		2014		2013		2014		2013
	Term loan	$	406,652	$	403,074	$	1,006,666	$	1,109,680
	Capitalized equipment leases		9,588		11,451		5,753		8,081
	Total long term debt	$	416,240	$	414,525	$	1,012,419	$	1,117,761
Summary of principal payments under Company's long term obligations	'
	12 month period ending March 31,
	2015	$	416,240
	2016		427,036
	2017		436,441
	2018		148,942
	Total	$	1,428,659

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Summary of computation of basic and diluted earnings per common share	'
		Three Months Ended
		March 31,
		2014		2013
	Earnings per common share -Basic
	Net income attributable to OBCI	$	223,598	$	349,052
	Weighted average number of common shares outstanding		8,690,074		8,398,385
	Earnings per common share - Basic	$	0.03	$	0.04
	Earnings per common share – Diluted
	Net income attributable to OBCI	$	223,598	$	349,052
	Weighted average number of common shares outstanding		8,690,074		8,398,385
	Dilutive effect of employee stock options		173,050		283,723
	Weighted average number of common shares outstanding - assuming dilution		8,863,124		8,682,108
	Earnings per common share - Diluted	$	0.03	$	0.04

Securities_Authorized_for_Issu1

Securities Authorized for Issuance under Equity Compensation Plans (Tables)	3 Months Ended
	Mar. 31, 2014
Securities Authorized for Issuance under Equity Compensation Plans [Abstract]	'
Schedule of outstanding stock options under Company's stock option plans	'
	Plan	Date	Options Outstanding		Exercisable	Exercise		Expiration	Weighted
		Granted			Options	Price		Date	Average
									Remaining Life
	2002NQ	4/3/06		40,000	40,000	$	1.08	4/2/16	2
	2002NQ	12/17/07		40,000	40,000	$	1.32	12/16/17	3.8
	2008NQ	1/11/09		40,000	40,000	$	0.69	1/10/19	4.9
	2008NQ	4/26/10		20,000	20,000	$	2.07	4/25/20	6.2
				140,000	140,000	$	1.18		3.9

Inventories_Details

Inventories (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Summary of composition of inventories	'	'
Raw materials	$3,642,178	$3,262,769
Finished goods	5,423,809	4,407,421
Inventories, gross	9,065,987	7,670,190
Inventory reserves	-302,296	-302,296
Inventories, net	$8,763,691	$7,367,894

Inventories_Details_Textual

Inventories (Details Textual) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Inventories (Textual)	'	'
Inventories managed at the customer's warehouses	$413,000	$408,000

Property_Plant_Equipment_Detai

Property, Plant, & Equipment (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014
			Building and improvements [Member]	Manufacturing and warehouse equipment [Member]	Manufacturing and warehouse equipment [Member]	Office equipment and furniture [Member]	Office equipment and furniture [Member]	Leasehold improvements [Member]	Leasehold improvements [Member]	Automobile [Member]
				Maximum [Member]	Minimum [Member]	Maximum [Member]	Minimum [Member]	Maximum [Member]	Minimum [Member]
Summary of property, plant and equipment	'	'	'	'	'	'	'	'	'	'
Land	$278,325	$278,325	'	'	'	'	'	'	'	'
Building and improvements	4,632,565	4,632,565	'	'	'	'	'	'	'	'
Manufacturing and warehouse equipment	8,160,173	8,160,173	'	'	'	'	'	'	'	'
Office equipment and furniture	834,505	830,950	'	'	'	'	'	'	'	'
Construction in process	160,103	19,604	'	'	'	'	'	'	'	'
Leasehold improvements	419,315	419,315	'	'	'	'	'	'	'	'
Automobile	32,263	32,263	'	'	'	'	'	'	'	'
Property, plant and equipment, gross	14,517,249	14,373,195	'	'	'	'	'	'	'	'
Less accumulated depreciation	-9,400,975	-9,256,754	'	'	'	'	'	'	'	'
Property, plant and equipment, net	$5,116,274	$5,116,441	'	'	'	'	'	'	'	'
Estimated Useful Life	'	'	'30 years	'20 years	'6 years	'5 years	'3 years	'15 years	'10 years	'3 years

Odorstar_Joint_Venture_Details

Odorstar Joint Venture (Details) (USD $)	0 Months Ended	3 Months Ended
	Aug. 06, 2013	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Odorstar Joint Venture (Textual)	'	'	'	'
Assets	'	$22,559,212	'	$22,243,124
Liabilities	'	4,450,896	'	3,971,048
Operating losses	'	351,769	524,926	'
OdorStar [Member]	'	'	'	'
Odorstar Joint Venture (Textual)	'	'	'	'
Assets	'	507,000	'	474,000
Liabilities	'	0	'	16,000
Operating losses	'	13,000	41,000	'
Purchased rights to royalties	160,000	'	'	'
Notes payable	'	$111,420	'	$111,420
Due date of notes payable	'	'December 2015	'	'

Revolving_Line_of_Credit_Detai

Revolving Line of Credit (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Revolving Line of Credit (Textual)	'	'
Term of revolving line of credit	'The Company may borrow up to the lesser of (i) $6 million or (ii) a borrowing base equal to 80% of eligible accounts receivable plus 50% of eligible inventory.	'
Maximum borrowing capacity of the company	$6	'
Percentage of eligible accounts receivables as part of borrowing base	80.00%	'
Percentage of eligible inventory as part of the borrowing base	50.00%	'
Description of interest on the revolving line of credit	'30 day LIBOR rate plus 1.74% per annum	'
Minimum debt service coverage ratio to qualify for LIBOR plus 1.74%	2	'
Alternate interest rate condition if it doesn't satisfy the debt coverage ratio	'30 day LIBOR rate plus 2.75% per annum	'
Interest rate minimum	2.00%	'
Due date of outstanding principal and interest borrowed under revolving line of credit	6-Jul-14	'
Financial covenants under credit agreement	'Minimum debt service coverage ratio of 1.75 to 1.00, tested on a rolling four-quarter basis, and a maximum debt to capitalization ratio (funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly.	'
Debt service coverage ratio	1.75	'
Debt capitalization ratio	0.75	'
Company's principal obligation under the revolving line of credit	'	'

Long_Term_Debt_Details

Long Term Debt (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Summary of long-term debt	'	'
Total long term debt, Current Portion	$416,240	$414,525
Total long term debt, Long Term Portion	1,012,419	1,117,761
Term loan [Member]	'	'
Summary of long-term debt	'	'
Total long term debt, Current Portion	406,652	403,074
Total long term debt, Long Term Portion	1,006,666	1,109,680
Capitalized equipment leases [Member]	'	'
Summary of long-term debt	'	'
Total long term debt, Current Portion	9,588	11,451
Total long term debt, Long Term Portion	$5,753	$8,081

Long_Term_Debt_Details_1

Long Term Debt (Details 1) (USD $)	Mar. 31, 2014
Summary of principal payments under Company's long term obligations	'
2015	$416,240
2016	427,036
2017	436,441
2018	148,942
Total	$1,428,659

Long_Term_Debt_Details_Textual

Long Term Debt (Details Textual) (USD $)	3 Months Ended		3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Jul. 06, 2011
			REFCO [Member]	REFCO [Member]
Long Term Debt (Textual)	'	'	'	'
Term loan	$1,413,000	'	'	$2,430,000
Interest rate	'	'	'	3.54%
Term loan maturity date	'	'	6-Jul-17	'
Aggregate capital lease	$15,341	$19,532	'	'
Maturity period for capital lease	'Through 2015	'	'	'
Interest rates minimum	7.00%	'	'	'
Interest rates maximum	14.00%	'	'	'

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Related Party Transactions (Textual)	'	'	'
Sales to the affiliated companies	$713,000	$471,000	'
Administrative fees	92,000	102,000	'
Accounts receivable from the affiliated companies	1,029,021	'	536,402
Amount paid to entity for services	10,500	10,500	'
Insurance premiums paid	$217,000	$183,000	'

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	1 Months Ended	3 Months Ended
	Mar. 27, 2014	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
		Fort Lauderdale Florida Facility [Member]	Fort Lauderdale Florida Facility [Member]	Alabama River Facility [Member]
				acre
Commitments (Textual)	'	'	'	'
Date lease was scheduled to expire	'	1-May-18	'	'
Date lease was extended to	'	31-Dec-23	'	'
Minimum base rent	'	$94,800	'	'
Maximum percentage increase in base rent	'	2.00%	'	'
Period to review term of lease	'	'3 years	'	'
Leased area for docking facility (in Acres)	'	'	'	1.5
Lease expiration date	'	'	'	30-Sep-14
Rent expense under the lease	'	24,000	25,000	8,000
Attorneys' fees and non-taxable costs	$259,550	'	'	'

Dividends_Details

Dividends (Details) (USD $)	3 Months Ended			1 Months Ended	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Mar. 18, 2014	Mar. 31, 2014
				Director [Member]	Director [Member]
Dividends (Textual)	'	'	'	'	'
Dividends per common share	$0.05	'	'	$0.05	'
Dividends payable, date to be paid	'	'	'	15-Apr-14	15-Apr-14
Common stock dividends, shares outstanding	8,800,314	'	'	'	'
Dividends payable	$440,016	'	'	'	'

Earnings_Per_Share_Details

Earnings Per Share (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Earnings per common share - Basic	'	'
Net income attributable to OBCI	$223,598	$349,052
Weighted average number of common shares outstanding	8,690,074	8,398,385
Earnings per common share - Basic	$0.03	$0.04
Earnings per common share - Diluted	'	'
Net income attributable to OBCI	$223,598	$349,052
Weighted average number of common shares outstanding	8,690,074	8,398,385
Effect of employee stock-based awards	173,050	283,723
Weighted average shares - diluted	8,863,124	8,682,108
Earnings per common share - Diluted	$0.03	$0.04
Earnings Per Share (Textual)	'	'
Anti-dilutive stock options outstanding	'	'

Securities_Authorized_for_Issu2

Securities Authorized for Issuance under Equity Compensation Plans (Details) (USD $)	3 Months Ended
	Mar. 31, 2014
Summary of outstanding options, exercisable options, exercise price, expiration date, weighted average remaining life under company stock option plans	'
Options Outstanding	140,000
Exercisable Options	140,000
Exercise Price	$1.18
Weighted Average Remaining Life	'3 years 10 months 24 days
2002NQ One [Member]	'
Summary of outstanding options, exercisable options, exercise price, expiration date, weighted average remaining life under company stock option plans	'
Date Granted	3-Apr-06
Options Outstanding	40,000
Exercisable Options	40,000
Exercise Price	$1.08
Expiration Date	2-Apr-16
Weighted Average Remaining Life	'2 years
2002NQ Two [Member]	'
Summary of outstanding options, exercisable options, exercise price, expiration date, weighted average remaining life under company stock option plans	'
Date Granted	17-Dec-07
Options Outstanding	40,000
Exercisable Options	40,000
Exercise Price	$1.32
Expiration Date	16-Dec-17
Weighted Average Remaining Life	'3 years 9 months 18 days
2002NQ Three [Member]	'
Summary of outstanding options, exercisable options, exercise price, expiration date, weighted average remaining life under company stock option plans	'
Date Granted	11-Jan-09
Options Outstanding	40,000
Exercisable Options	40,000
Exercise Price	$0.69
Expiration Date	10-Jan-19
Weighted Average Remaining Life	'4 years 10 months 24 days
2002NQ Four [Member]	'
Summary of outstanding options, exercisable options, exercise price, expiration date, weighted average remaining life under company stock option plans	'
Date Granted	26-Apr-10
Options Outstanding	20,000
Exercisable Options	20,000
Exercise Price	$2.07
Expiration Date	25-Apr-20
Weighted Average Remaining Life	'6 years 2 months 12 days

Securities_Authorized_for_Issu3

Securities Authorized for Issuance under Equity Compensation Plans (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Securities Authorized for Issuance under Equity Compensation Plans (Textual)	'	'
Shares of stock awards	'	'
Stock option exercised	145,000	'
Number of shares withhold in connection with net exercise feature of options	14,633	'
Shares issued to option holders shares	130,367	'
Stock compensation expense attributable to stock options	$0	$5,000
Unrecognized compensation expense related to stock options awarded to employees	'	'